Metachromatic Leukodystrophy (MLD)
11 clinical trials · Condition
◉ Watch Metachromatic Leukodystrophy (MLD)
| Record | Firm | Date |
|---|---|---|
| A Study of Intrathecal SHP611 in Children With Metachromatic Leukodystrophy (NCT03771898) | Shire | 2019-05-13 |
| Natural History Study of Children With Metachromatic Leukodystrophy (NCT01963650) | Shire | 2015-11-02 |
| An Efficacy and Safety Study of HGT-1110 in Participants With Metachromatic Leukodystrophy (NCT01887938) | Shire | 2013-05-23 |
| Multicenter Study of HGT-1110 Administered Intrathecally in Children With Metachromatic Leukodystrophy (MLD) (NCT01510028) | Shire | 2012-02-02 |
| Phase I/II Pilot Study of Mixed Chimerism to Treat Inherited Metabolic Disorders (NCT01372228) | Talaris Therapeutics Inc. | 2011-04-01 |
| Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford (NCT01793168) | Sanford Health | 2010-07-01 |
| Allogeneic Bone Marrow Transplant for Inherited Metabolic Disorders (NCT01043640) | Masonic Cancer Center, University of Minnesota | 2009-12-01 |
Track Metachromatic Leukodystrophy (MLD) automatically
Every clearance here is in the API, with alerts when new ones post.